This study was purposed to investigate the expression of B7-H1 gene in
leukemia cells and its clinical significance. The expression of B7-H1
mRNA was detected by
SYBR Green I real-time quantitative PCR in a panel of 9
leukemia cell lines, 4
leukemia cell lines induced with IFN-γ, the bone marrow mononuclear cells (BMMNC) from 59 initial
leukemia patients and 10 dendritic cells (DC) derived from BMMNC of initial
leukemia patients, 2 solid tumour cell lines and BMMNC from 10 normal persons. The correlation between the clinical features of 59 acute
leukemia patients and the expression level of B7-H1
mRNA in
leukemia cells was analyzed. The results showed that the lower level of B7-H1
mRNA expression was found in
leukemia cell lines and primary acute
leukemia cells, but the expression level of B7-H1
mRNA was up-regulated significantly in the
leukemia cell lines induced by IFN-γ and DC derived from BMMNC of
leukemia patients. The expression level of B7-H1
mRNA in non complete remission (CR) patients after
therapy was significantly higher than that in CR patients. It is concluded that the expression level of B7-H1
mRNA in
leukemia cells is lower, but is up-regulated when affected by some factors. A correlation exists between the expression level of B7-H1 gene in
leukemia cells and response of patients to
therapy.